a * *JECFA ADI - 2 -

Similar documents
求人面接資料PPT

初めに:

APR. JUL. AUG. MAY JUN. 2

極地研 no174.indd

本文

VOL.42 S-1

_2009MAR.ren

contents


欧州に見るマイナス金利が銀行に及ぼす影響


VOL. 23 NO. 3 CHEMOTHERAPY 1067 Table 2 Sensitivity of gram positive cocci isolated from various diagnostic materials Table 3 Sensitivity of gram nega

untitled

08-g-”O−}„j‹ê-4.02

請求記号:DVD 70- -1  栄光のフィレンツェ・ルネサンス  1 夜明け   55分 

VOL. 34 S-2 CHEMOTH8RAPY 913

Dec. THE JAPANESE JOURNAL OF ANTIBIOTICS XXXVII (45)

PubMedとは

CHEMOTHERAPY MAY. 1988

CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Fig. 2 Body weight curves rats treated orally with DL-8280 for 4 weeks


有明海・八代海総合調査評価委員会 委員会報告書 別添資料

日本消化器外科学会雑誌第29巻第9号

CHEMOTHERAPY Table 1 Urinary excretion of mezlocillin Fig. 4 Urinary excretion of mezlocillin Fig. 3 Blood levels of mezlocillin

VOL. 36 S-3 CHEMOTHERAPY 437



Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.


VOL. 40 S- 1 Table 1. Susceptibility of methicillin-resistant Staphylococcus aureus to meropenem Table 2. Coagulase typing of methicillin-resistant St

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human

PBO 2000~ PBO Funded Ratio - 12/31/93 to Present 140% 130% 120% 110% 100% 90% 82.6% as of 7/31/ % 70% 81.6% as of YE % 1993

VOL. 23 NO. 3 CHEMOTHERAPY 1379 Table 1 Susceptibility of clinical isolated strains to Tobramycin

PubMed 1. CD-ROM MEDLINE MeSH PubMed 2. Automatic Term Mapping MeSH 3. Related Article MeSH Browser MeSH PreMEDLINE MeSH -2-

EBM Reviews Ovid Ovid EBM Reviews ACP Journal Club Cochrane Database of Systematic Revie

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

Fig. 1 Chemical structure of KW-1070

untitled

988 CHEMOTHERAPY NOV. 1971

Table 1. Influence of food deprivation on gastric secretion and severity of ulceration in 18 hr pylorus ligated rats.

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

DIALOG MEDLINE...1 BIOSIS PREVIEWS...7 DIOGENES: ADVERSE DRUG EVENTS DATABASE PHARMAPROJECTS...21 IMS R&D FOCUS...22 DATASTAR..

第33回 ESRI-経済政策フォーラム


Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

untitled

CHEMOTHERAPY

CHEMOTHERAPY Table 1 Clinical effect of Sultamicillin

CHEMOTHERAPY FEB Table 1 Background of volunteers

福光 寛 1‐37/1‐37

AUTONOMIC FUNCTIONAL STATE IN RENAL TUBERCULOSIS REPORT III. SERUM CHOLINESTERASE ACTIVITY IN RENAL TUBERCULOSIS Sanai Yamamura The Department of Urol

AAS48.indd

ミニレビュー


1272 CHEMOTHERAPY MAR. 1975

62 No.11


Key words: E. coli O 157: H7, fosfomycin, verotoxin, mouse infection

Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL Right Posted at the Inst

VOL. 20 NO. 5 CHEMOTHERAPY Methoxy-4-sulfanilamidopyrimidine (OS-3376) Sulfadimethoxine (SDM) Table 1. In vitro antibacterial activities of OS-3

Clostridium difficile ciprofloxacin, ofloxacin, norfloxacin Bifidobacterium Lactobacillus Lactobacillus Bacteroides fragilis B. fragilis C. difficile

CHEMOTHERAPY APR. 1984

CHEMOTHERAPY DEC Table 1 Antibacterial spectra of T-1982, CTT, CMZ, CTX, CPZ and CEZ 106 CFU/ml Note: P; Peptococcus, S; Streptococcus, G; Gaffk

Regular Midgrade Premium Total Conventional % 56.6% 58.1% 64.6% Oxygenated % 5.3% 1.7% 3.2% Reformulated

î› ›ƒfi‘ÿìäéëóø01

Taro13-第2章まとめ(最終).PDF

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

Effect of Sympathetic and parasympathetic agents on cholesterol metabolism in mice salivary glands. Eriko, NEZU and Haruo, NAKAMURA (Department of Ora

9 : : : : : : : : : 00

日本化学療法学会雑誌第59巻第5号

untitled

CHEMOTHERAPY


VOL.47 NO.5 Table 1. Susceptibility distribution of Ĉ- lactams against clinical isolates of MRSA MRSA: rnethicillin- resistant Staphylococcus aureus

untitled

untitled

2015壺溪塾表1表4_0105

研究成果報告書(基金分)

Fig. 1 Chemical structure of DL-8280

報告書

Mikio Yamamoto: Dynamical Measurement of the E-effect in Iron-Cobalt Alloys. The AE-effect (change in Young's modulus of elasticity with magnetization


56 pp , 2005 * ******* *** ** CA CAMA

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

VOL. 43 NO. 4

CAS NC(CH 2 ) 4 CN 1,4- C 6 H 8 N c.c d = Pa

CHEMOTHERAPY Fig. 1 Chemical structure of CXM-AX

Rinku General Medical Center

Key words: change serotype, Pseudomonas aeruginosa anti-pseudomonal drug,

CHEMOTHERAPY JUNE 1986

技術研究報告第26号

THE JAPANESE JOURNAL OF ANTIBIOTICS XXII-4 Aug. viable cell number was counted, the number decreased remarkably, then increasedrapidly number as the c

研究成果報告書


CHEMOTHERAPY NOV S. aureus, S. epidermidis, E. coli, K. pgeumoniae, E. cloacae, S. marcescens, P. mirabilis, Proteus, P. aeruginosa Inoculum siz

untitled

Transcription:

5-10 ADI 5-10 a 7 1-3 4 5 b c a Letter to Editor 7 1-3 3 d b b a 1 1969 a Table 3 8 72.5% 2.5 60% 372 2 * Table 3 2.5 4 mg/kg 12 32% 60 62% * a 2.5 10 40% 20% 25 BALB/cAJcl 40% 55 C3H/HeNJcl-MTV+ 2.5 4 mg/kg 12 32% 60 62% 1 50-1 -

a 2 5-1 * *JECFA ADI - 2 -

a 2 0 0.4 4.0 400 mg/kg (1970) 2 / 50% 8-10g 15-20g 5 (%) 0 mg/kg 57 0.4 mg/kg 65.5 4.0 mg/kg 51.6 400 mg/kg 30 3 0 4.0 mg/kg / 8-10g 2.5 (%) 60 62 12 32 17 0 2 mg/kg / b 9 11-12g (1969) 4 mg/kg (1,000 RU/mg) 80 mg/kg (50 RU/mg) c 8 18 0 0.4 4.0 400 mg/kg (1965) / 3 10-20g 0% 40% 50% (8-25g?) JECFA (1968) [2-4] FDA (1984) [2-11] a (1970) b (1969) c (1965) EU (SCF) (1990) 2 3 No adverse effects were (1982) [2-13-a] observed.

5-10 2004 6 11 A. PubMED NLM PubMED 23 Search Most Recent Queries Result #1 Search mortality Field: All Fields 434152 #2 Search mouse Field: All Fields 718874 #3 Search sensitivity or susceptibility Field: Title/Abstract 342486 #4 Search aging/physiology Field: MeSH Terms 54116 #5 Search #1 AND #2 AND #3 AND #4 23 23 13 8 2 22 1 6. Clin Diagn Lab Immunol. 2001 Sep;8(5):1003-11. Effects of calorie restriction on polymicrobial peritonitis induced by cecum ligation and puncture in young C57BL/6 mice. 7. J Biol Chem. 2001 Aug 3;276(31):29307-12. Epub 2001 May 29. Age-associated differences in cardiovascular inflammatory gene induction during endotoxic stress. 24-26 4 LPS 8. J Immunol. 1999 Sep 1;163(5):2777-82. Role of IL-10 in a neonatal mouse listeriosis model. IL-10 1

12. Scand J Immunol. 1997 Nov;46(5):469-78. Increased mortality and impaired clonal deletion after staphylococcal enterotoxin B injection in old mice: relation to cytokines and nitric oxide production. B IFN- FAS TNF- 13 Exp Anim. 1997 Jul;46(3):211-8. Age-related changes in susceptibility of mice to low-virulent mouse hepatitis virus (MHV-2-CC) infection. 1 2 3 4 100 36 0 16. Mech Ageing Dev. 1994 Feb;73(2):145-55. Differences between young and aged mice in susceptibility to Friend virus. Freined Virus, FV 18. J Infect Dis. 1993 Aug;168(2):352-7. Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection. 18 2 T 22. J Nutr. 1987 Oct;117(10):1671-5. Toxicity of palmitoyl glycerol to mice: hypothermia and reversal of the toxicity. rac-1(3)-palmitoyl glycerol Palmitoyl glycerol 6 28 palmitoyl glycerol 28 34 palmitoyl glycerol 2

23. J Immunol. 1987 Jun 15;138(12):4414-8. Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. 3 18 T 24 28 3

B. DIALOG 1 DIALOG 7 MEDLINE EMBASE ToxFile BIOSIS PREVIEWS FOODLINE FSTA JICST Set Items Description S1 2485957 MOUSE OR MICE S2 1404035 SUSCEPTIBILITY OR SENSITIVITY S4 2843446 AGE OR AGING S5 944285 MORTALITY S6 423 S1 AND S2 AND S4 AND S5 S7 20 S6 AND ORAL S8 15 RD S7 (unique items) 15 2 5 6 1 8 5 Japanese journal of experimental medicine 1975, 45 (4) p285-92 Pathogenicity of mouse hepatitis virus for mice depending upon host age and route of infection. day-old 4 3 1 2 6. Journal of Comparative Pathology ( J. COMP. PATHOL. 2004, 130/1 (58-65) Neurotropism of swine haemagglutinating encephalomyelitis virus (coronavirus) in mice depending upon host age and route of infection 1 4 8 1 4 8 4

8. Experimental Lung Research ( EXP. LUNG RES. ) (United States) 1993, 19/3 (299-314) Factors that influence the suppression of pulmonary antibacterial defenses in mice exposed to ozone Streptococcus zooepidemicus 5 9 0.4 0.8 ppm 20 PGE 2 5

C. DIALOG 2 biopreservatives antibiotics mortality 9 5-10 4 Set Items Description S1 2487511 MOUSE OR MICE S2 1405370 SUSCEPTIBILITY OR SENSITIVITY S3 2845837 AGE OR AGING S4 620112 BIOPRESERVATIVE? OR ANTIBIOTIC? S5 59 S1 AND S2 AND S3 AND S4 S6 42 RD S5 (unique items) S7 9 S6 AND ORAL 2 3. Infection and immunity (UNITED STATES) Jan 1982, 35 (1) p222-8, Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy. Candida albicans 4 6 10 11 4. Antibiotiki (USSR) Oct 1976, 21 (10) p904-10 9 [Dependence of the toxicity of the antineoplastic antibiotics rubomycin and carminomycin, on the age and sex of white mice and rats] Karminomycin 2-6 5-6 Karminomycin stable Karminomycin 2 23 Karminomycin Rubomycin LD 50 6

2004/8/26 NISIN EDI mg/ / 1 1 non-standardised 0.55 2 0.6 3 2.15 60 kg 0.036 mg/kg / EU EDI 1 0.008 4 *1 EDI TMDI Theoretical Mazimum Daily Intakes *2 p.5 5 1 Federal Register 53 FR 11247, Apr. 6, 1988, Food and Drug Administration, HHS. 2-2 2 DANISCO CONFIDENTIAL NISIN Feb 2003 3 Agency Response Letter GRAS Notice No.GRN 000065 2-9 4 Danisco 5 Official Journal of the European Communities 1995 L Volume 2-12